Induction donor-type chimerism murine recipients bone marrow allografts different radiation regimens treatment leukemia patients radiation protocols treatment leukemia patients bone marrow transplantation BMT murine model BM allograft rejection single dose total body irradiation Gy TBI dose rate Gy/min TBI Gy fractions Gy day days dose rate Gy/min TBI Gy fractions Gy times day days dose rate Gy/min Donor-type chimerism weeks BMT hematologic reconstitution day BMT groups results mice Gy TBI dose rate Gy/min murine model results parameters marked advantage single dose Gy TBI treatments advantage equivalent three- increment BM inoculum hyperfractionated radiation favorable conditions development donor-type chimerism fractionated radiation protocol equivalent efficacy results mice single-dose Gy TBI significant advantage protocol model effect radiation dose rate development donor-type chimerism significant enhancement increase dose rate Gy/min Further enhancement dose rate Gy/min survival high dose rate results dose rate expression host-type pluripotent stem cells progeny weeks treatment Gy TBI dose rate Gy/min radiation dose rate Gy/min 